- Home
- CYRX vs BNTC Comparison
CYRX vs BNTC Comparison
Compare CYRX & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CYRX | BNTC |
|---|---|---|
| Founded | 1999 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 438.7M | 405.7M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | CYRX | BNTC |
|---|---|---|
| Price | $9.40 | $11.97 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 4 |
| Target Price | $12.83 | ★ $28.25 |
| AVG Volume (30 Days) | ★ 590.7K | 235.3K |
| Earning Date | 11-04-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.27 | N/A |
| Revenue | ★ $243,795,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $9.26 | N/A |
| P/E Ratio | $7.44 | ★ N/A |
| Revenue Growth | ★ 41.27 | N/A |
| 52 Week Low | $4.58 | $9.70 |
| 52 Week High | $11.44 | $17.15 |
Technical Indicators
Market Signals| Indicator | CYRX | BNTC |
|---|---|---|
| Relative Strength Index (RSI) | 49.73 | 38.63 |
| Support Level | $9.08 | $12.78 |
| Resistance Level | $10.30 | $13.68 |
| Average True Range (ATR) | 0.46 | 0.76 |
| MACD | 0.05 | 0.03 |
| Stochastic Oscillator | 42.94 | 22.20 |
Price Performance
Historical ComparisonAbout CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.